Nonetheless, cancer-associated macrophage-like cells (CAMLs), which may also be identified as hybrids due to their multinucleated structure and expression of CD14+, CD45+, cytokeratin+, and EpCAM+ markers, have been observed to cluster with CTCs at primary tumour sites (Figure 2). The gene discussed is EPCAM; the disease is neoplasm.